These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16535872)

  • 1. [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life].
    Lökk J; Winblad B
    Lakartidningen; 2006 Feb 15-21; 103(7):451-5. PubMed ID: 16535872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dementia in Parkinson's disease].
    Halvorsen Ø; Tysnes OB
    Tidsskr Nor Laegeforen; 2007 Oct; 127(19):2517-20. PubMed ID: 17925819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease dementia--a first step?
    Press DZ
    N Engl J Med; 2004 Dec; 351(24):2547-9. PubMed ID: 15590960
    [No Abstract]   [Full Text] [Related]  

  • 4. [Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing].
    Larsson A
    Lakartidningen; 2006 May 10-16; 103(19):1537; discussion 1537-8. PubMed ID: 16805251
    [No Abstract]   [Full Text] [Related]  

  • 5. [Emotional and cognitive disorders in Parkinson disease].
    Arsland D; Larsen JP
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive deterioration in Parkinson's disease].
    Perea-Bartolomé MV
    Rev Neurol; 2001 Jun 16-30; 32(12):1182-7. PubMed ID: 11562851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
    Maidment ID; Fox C; Boustani M
    Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
    Coelho M; Ferreira J; Rosa M; Sampaio C
    Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rivastigmine against dementia in Parkinson disease?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
    Leroi I; Collins D; Marsh L
    J Neurol Sci; 2006 Oct; 248(1-2):104-14. PubMed ID: 16806271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
    Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dementia].
    Diehl RR
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):617-28. PubMed ID: 14608514
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug treatment is beneficial also for elderly patients with Parkinson disease. Important to consider also other co-existing diseases].
    Granérus AK
    Lakartidningen; 2001 Mar; 98(13):1515-23. PubMed ID: 11330147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.